Invention Grant
- Patent Title: Prodrugs of inhibitors of plasma kallikrein
- Patent Title (中): 血浆激肽释放酶抑制剂的前药
-
Application No.: US13445614Application Date: 2012-04-12
-
Publication No.: US08691861B2Publication Date: 2014-04-08
- Inventor: Sukanto Sinha , Tamie Jo Chilcote , Joghee Raju Suresh , Sriram Narasimhan
- Applicant: Sukanto Sinha , Tamie Jo Chilcote , Joghee Raju Suresh , Sriram Narasimhan
- Applicant Address: US CA San Francisco
- Assignee: ActiveSite Pharmaceuticals, Inc.
- Current Assignee: ActiveSite Pharmaceuticals, Inc.
- Current Assignee Address: US CA San Francisco
- Agency: Kilpatrick Townsend & Stockton LLP
- Agent William B. Kezer
- Main IPC: C07D207/34
- IPC: C07D207/34 ; C07D231/14
Abstract:
This invention provides new pharmaceutically useful compounds that are prodrugs of inhibitors of plasma kallikrein and methods and compositions for preventing or treating plasma kallikrein dependent diseases or conditions, such as diabetic macular edema or hemorrhagic stroke, by administering prodrugs of the formula:
Public/Granted literature
- US20120264798A1 PRODRUGS OF INHIBITORS OF PLASMA KALLIKREIN Public/Granted day:2012-10-18
Information query
